Insider Transactions in Q4 2022 at Kymera Therapeutics, Inc. (KYMR)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Indirect |
717
-0.08%
|
$21,510
$30.0 P/Share
|
|
Dec 15
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Direct |
2,561
-0.05%
|
$76,830
$30.0 P/Share
|
|
Dec 15
2022
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
3,278
-0.06%
|
$98,340
$30.0 P/Share
|
|
Dec 14
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Indirect |
82,889
-1.71%
|
$2,652,448
$32.28 P/Share
|
|
Dec 14
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Direct |
296,077
-1.13%
|
$9,474,464
$32.28 P/Share
|
|
Dec 14
2022
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
378,966
-1.42%
|
$12,126,912
$32.28 P/Share
|
|
Dec 08
2022
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.71%
|
$20,000
$2.08 P/Share
|
|
Nov 03
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Indirect |
21,085
-2.06%
|
$632,550
$30.0 P/Share
|
|
Nov 03
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Direct |
75,312
-1.38%
|
$2,259,360
$30.0 P/Share
|
|
Nov 03
2022
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
96,397
-1.72%
|
$2,891,910
$30.0 P/Share
|
|
Nov 02
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Indirect |
27,038
-2.58%
|
$811,140
$30.02 P/Share
|
|
Nov 02
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Direct |
96,581
-1.74%
|
$2,897,430
$30.02 P/Share
|
|
Nov 02
2022
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
123,619
-2.16%
|
$3,708,570
$30.02 P/Share
|
|
Nov 01
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Indirect |
16,848
-0.79%
|
$505,440
$30.83 P/Share
|
|
Nov 01
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Direct |
60,182
-0.54%
|
$1,805,460
$30.83 P/Share
|
|
Nov 01
2022
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
77,030
-0.66%
|
$2,310,900
$30.83 P/Share
|
|
Oct 31
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Indirect |
26,383
-2.41%
|
$791,490
$30.23 P/Share
|
|
Oct 31
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Direct |
94,239
-1.66%
|
$2,827,170
$30.23 P/Share
|
|
Oct 31
2022
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
120,622
-2.04%
|
$3,618,660
$30.23 P/Share
|
|
Oct 28
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Indirect |
19,915
-1.79%
|
$597,450
$30.0 P/Share
|
|
Oct 28
2022
|
Atlas Venture Fund X, L.P. |
SELL
Open market or private sale
|
Direct |
71,135
-1.23%
|
$2,134,050
$30.0 P/Share
|
|
Oct 28
2022
|
Bruce Booth |
SELL
Open market or private sale
|
Indirect |
91,050
-1.51%
|
$2,731,500
$30.0 P/Share
|
|
Oct 21
2022
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.96%
|
$20,000
$2.08 P/Share
|
|
Oct 17
2022
|
Nello Mainolfi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,732
+5.18%
|
$119,464
$2.08 P/Share
|
|
Oct 17
2022
|
Bruce N. Jacobs Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+12.3%
|
$20,000
$2.08 P/Share
|